United Therapeutics (UTHR) Equity Ratio (2016 - 2026)
United Therapeutics' Equity Ratio history spans 17 years, with the latest figure at 0.9 for Q4 2025.
- On a quarterly basis, Equity Ratio rose 2.91% to 0.9 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.9, a 2.91% increase, with the full-year FY2025 number at 0.9, up 2.91% from a year prior.
- Equity Ratio hit 0.9 in Q4 2025 for United Therapeutics, roughly flat from 0.9 in the prior quarter.
- Over the last five years, Equity Ratio for UTHR hit a ceiling of 0.91 in Q2 2025 and a floor of 0.74 in Q1 2021.
- Historically, Equity Ratio has averaged 0.82 across 5 years, with a median of 0.81 in 2023.
- Biggest five-year swings in Equity Ratio: grew 1.37% in 2021 and later increased 7.05% in 2025.
- Tracing UTHR's Equity Ratio over 5 years: stood at 0.77 in 2021, then increased by 3.61% to 0.79 in 2022, then rose by 5.23% to 0.84 in 2023, then grew by 4.79% to 0.88 in 2024, then rose by 2.91% to 0.9 in 2025.
- Business Quant data shows Equity Ratio for UTHR at 0.9 in Q4 2025, 0.9 in Q3 2025, and 0.91 in Q2 2025.